K&L Gates advised Rocket, and Latham advised underwriters.Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common stock…
Rocket Pharmaceuticals’ $175 Million Public Offering
